| Year |
Citation |
Score |
| 2020 |
Harane NE, Correa BL, Gomez I, Hocine HR, Vilar J, Desgres M, Bellamy V, Keirththana K, Guillas C, Perotto M, Pidial L, Alayrac P, Tran T, Tan S, Hamada T, ... ... Al-Daccak R, et al. Extracellular Vesicles from Human Cardiovascular Progenitors Trigger a Reparative Immune Response in Infarcted Hearts. Cardiovascular Research. PMID 32049348 DOI: 10.1093/Cvr/Cvaa028 |
0.339 |
|
| 2019 |
Berrazouane S, Boisvert M, Salti S, Mourad W, Al-Daccak R, Barabé F, Aoudjit F. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia. Cell Death & Disease. 10: 357. PMID 31043590 DOI: 10.1038/S41419-019-1593-2 |
0.317 |
|
| 2017 |
Dam N, Hocine HR, Palacios I, DelaRosa O, Menta R, Charron D, Bensussan A, El Costa H, Jabrane-Ferrat N, Dalemans W, Lombardo E, Al-Daccak R. Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair. Frontiers in Immunology. 8: 1413. PMID 29123530 DOI: 10.3389/Fimmu.2017.01413 |
0.361 |
|
| 2017 |
Sanz-Ruiz R, Casado Plasencia A, R Borlado L, Fernández-Santos ME, Al-Daccak R, Claus P, Palacios I, Sádaba R, Charron D, Bogaert J, Mulet M, Yotti R, Gilaberte I, Bernad A, Bermejo J, et al. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human CARdiac stEm Cells in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial. Circulation Research. PMID 28533209 DOI: 10.1161/Circresaha.117.310651 |
0.309 |
|
| 2017 |
Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Benssusan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R. Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Scientific Reports. 7: 41125. PMID 28117403 DOI: 10.1038/Srep41125 |
0.438 |
|
| 2015 |
Siewiera J, Gouilly J, Hocine HR, Cartron G, Levy C, Al-Daccak R, Jabrane-Ferrat N. Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes. Nature Communications. 6: 10183. PMID 26666685 DOI: 10.1038/Ncomms10183 |
0.368 |
|
| 2015 |
Al-Daccak R, Charron D. Allogenic benefit in stem cell therapy: cardiac repair and regeneration. Tissue Antigens. 86: 155-162. PMID 26206374 DOI: 10.1111/Tan.12614 |
0.321 |
|
| 2015 |
Hocine HR, Lauden L, Dam N, Boukouaci W, Charron D, Al-Daccak R. Lbp03: Allogeneic-Driven Benefit Of Human Cardiac-Derived Stem/Progenitor Cells Human Immunology. 76: 213. DOI: 10.1016/J.Humimm.2015.01.035 |
0.474 |
|
| 2014 |
Boukouaci W, Lauden L, Siewiera J, Dam N, Hocine HR, Khaznadar Z, Tamouza R, Borlado LR, Charron D, Jabrane-Ferrat N, Al-Daccak R. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovascular Research. 104: 290-302. PMID 25213554 DOI: 10.1093/Cvr/Cvu208 |
0.379 |
|
| 2014 |
Lauden L, Siewiera J, Boukouaci W, Ramgolam K, Mourah S, Lebbe C, Charron D, Aoudjit F, Jabrane-Ferrat N, Al-Daccak R. TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential. The Journal of Investigative Dermatology. 134: 1675-85. PMID 24499734 DOI: 10.1038/Jid.2014.20 |
0.335 |
|
| 2013 |
Boukouaci W, Al-Daccak R, Dulphy N, Lauden L, Amokrane K, Fortier C, Marzais F, Bennabi M, Peffault de Latour R, Socie G, Toubert A, Charron D, Krishnamoorthy R, Tamouza R. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease. Human Immunology. 74: 1536-41. PMID 23994587 DOI: 10.1016/J.Humimm.2013.08.281 |
0.433 |
|
| 2013 |
Vogel R, Al-Daccak R, Drews O, Alonzeau J, Mester G, Charron D, Stevanovic S, Mallet J. Mass spectrometry reveals changes in MHC I antigen presentation after lentivector expression of a gene regulation system. Molecular Therapy. Nucleic Acids. 2: e75. PMID 23403517 DOI: 10.1038/Mtna.2013.3 |
0.435 |
|
| 2013 |
Lauden L, Boukouaci W, Borlado LR, López IP, Sepúlveda P, Tamouza R, Charron D, Al-Daccak R. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. Circulation Research. 112: 451-64. PMID 23243206 DOI: 10.1161/Circresaha.112.276501 |
0.316 |
|
| 2013 |
Lauden L, Boukouaci W, Dam N, Tamouza R, Charron D, Al-Daccak R. 39-Or: Allogenicity Of Human Cardiac Stem/Progenitor Cells Human Immunology. 74: 30. DOI: 10.1016/J.Humimm.2013.08.050 |
0.399 |
|
| 2012 |
Charron D, Suberbielle-Boissel C, Tamouza R, Al-Daccak R. Anti-HLA antibodies in regenerative medicine stem cell therapy. Human Immunology. 73: 1287-94. PMID 22789622 DOI: 10.1016/J.Humimm.2012.06.010 |
0.368 |
|
| 2012 |
Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D, Al-Daccak R, Aoudjit F. α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). The Journal of Biological Chemistry. 287: 17065-76. PMID 22457358 DOI: 10.1074/Jbc.M112.349365 |
0.369 |
|
| 2012 |
Ghislin S, Deshayes F, Lauriol J, Middendorp S, Martins I, Al-Daccak R, Alcaide-Loridan C. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth. Melanoma Research. 22: 184-94. PMID 22454190 DOI: 10.1097/Cmr.0B013E328351E7C4 |
0.344 |
|
| 2011 |
Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, de la Grange P, Khatib AM, Aoudjit F, Charron D, Alcaide-Loridan C, Al-Daccak R. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. Plos One. 6: e18784. PMID 21526207 DOI: 10.1371/Journal.Pone.0018784 |
0.323 |
|
| 2011 |
Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L. MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 186: 5173-83. PMID 21441454 DOI: 10.4049/Jimmunol.1002050 |
0.507 |
|
| 2009 |
Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean MC, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Research. 19: 226-37. PMID 19574933 DOI: 10.1097/Cmr.0B013E32832E0Bc3 |
0.476 |
|
| 2008 |
Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Molecular Cancer Research : McR. 6: 42-52. PMID 18234961 DOI: 10.1158/1541-7786.Mcr-07-0080 |
0.405 |
|
| 2008 |
Doisne JM, Castaigne JG, Deruyffelaere C, Dieu-Nosjean MC, Chamot C, Alcaide-Loridan C, Charron D, Al-Daccak R. The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes. Molecular Immunology. 45: 709-18. PMID 17719638 DOI: 10.1016/J.Molimm.2007.07.019 |
0.523 |
|
| 2007 |
Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. European Journal of Immunology. 37: 788-97. PMID 17304627 DOI: 10.1002/Eji.200636620 |
0.46 |
|
| 2004 |
Baton F, Deruyffelaere C, Chapin M, Prod'homme T, Charron D, Al-Daccak R, Alcaide-Loridan C. Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Research. 14: 453-61. PMID 15577315 DOI: 10.1097/00008390-200412000-00004 |
0.512 |
|
| 2004 |
Aoudjit F, Guo W, Gagnon-Houde JV, Castaigne JG, Alcaide-Loridan C, Charron D, Al-Daccak R. HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells. Experimental Cell Research. 299: 79-90. PMID 15302575 DOI: 10.1016/J.Yexcr.2004.05.011 |
0.717 |
|
| 2004 |
Al-Daccak R, Mooney N, Charron D. MHC class II signaling in antigen-presenting cells. Current Opinion in Immunology. 16: 108-13. PMID 14734118 DOI: 10.1016/J.Coi.2003.11.006 |
0.5 |
|
| 2003 |
Guo W, Castaigne JG, Mooney N, Charron D, Al-Daccak R. Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts. European Journal of Immunology. 33: 928-38. PMID 12672059 DOI: 10.1002/Eji.200323351 |
0.716 |
|
| 2002 |
Lévéille C, Castaigne JG, Charron D, Al-Daccak R. MHC class II isotype-specific signaling complex on human B cells. European Journal of Immunology. 32: 2282-91. PMID 12209641 DOI: 10.1002/1521-4141(200208)32:8<2282::Aid-Immu2282>3.0.Co;2-M |
0.519 |
|
| 2002 |
Castaigne JG, Guo W, Lévéille C, Charron D, Al-Daccak R. A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes. International Immunology. 14: 1003-14. PMID 12202398 DOI: 10.1093/Intimm/Dxf071 |
0.698 |
|
| 2002 |
Etongué-Mayer P, Langlois MA, Ouellette M, Li H, Younes S, Al-Daccak R, Mourad W. Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the beta chain. European Journal of Immunology. 32: 50-8. PMID 11754003 DOI: 10.1002/1521-4141(200201)32:1<50::Aid-Immu50>3.0.Co;2-A |
0.457 |
|
| 1999 |
Léveillé C, Chandad F, Al-Daccak R, Mourad W. CD40 associates with the MHC class II molecules on human B cells European Journal of Immunology. 29: 3516-3526. PMID 10556806 DOI: 10.1002/(Sici)1521-4141(199911)29:11<3516::Aid-Immu3516>3.0.Co;2-D |
0.489 |
|
| 1999 |
Guo W, Mourad W, Charron D, Al-Daccak R. Ligation of MHC class II molecules differentially upregulates TNF beta gene expression in B cell lines of different MHC class II haplotypes. Human Immunology. 60: 312-22. PMID 10363722 DOI: 10.1016/S0198-8859(98)00131-1 |
0.697 |
|
| 1999 |
Léveillé C, Zekki H, Al-Daccak R, Mourad W. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities International Immunology. 11: 719-730. PMID 10330277 DOI: 10.1093/Intimm/11.5.719 |
0.506 |
|
| 1999 |
Thibeault A, Zekki H, Mourad W, Charron D, Al-Daccak R. Triggering HLA-DR molecules on human peripheral monocytes induces their death Cellular Immunology. 192: 79-85. PMID 10066350 DOI: 10.1006/Cimm.1998.1428 |
0.517 |
|
| 1999 |
Léveillé C, Al-Daccak R, Mourad W. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines European Journal of Immunology. 29: 65-74. PMID 9933087 DOI: 10.1002/(Sici)1521-4141(199901)29:01<65::Aid-Immu65>3.0.Co;2-E |
0.457 |
|
| 1998 |
Dimitriadou V, Mécheri S, Koutsilieris M, Fraser W, Al-Daccak R, Mourad W. Expression of functional major histocompatility complex class II molecules on HMC-1 human mast cells Journal of Leukocyte Biology. 64: 791-799. PMID 9850162 DOI: 10.1002/Jlb.64.6.791 |
0.435 |
|
| 1997 |
Bernatchez C, Al-Daccak R, Mayer PE, Mehindate K, Rink L, Mecheri S, Mourad W. Functional analysis of mycoplasma arthritidis-derived mitogen interactions with class ii molecules Infection and Immunity. 65: 2000-2005. PMID 9169724 DOI: 10.1128/Iai.65.6.2000-2005.1997 |
0.481 |
|
| 1997 |
Léveillé C, Al-Daccak R, Mourad W. CD40 and MHC class II molecules: inducers of cell death Biochemistry and Cell Biology. 75: 473. DOI: 10.1139/abstract21 |
0.381 |
|
| 1996 |
Mehindate K, Al-Daccak R, Damdoumi F, Mourad W. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression European Journal of Immunology. 26: 2075-2080. PMID 8814249 DOI: 10.1002/Eji.1830260917 |
0.502 |
|
| 1995 |
Mahana W, Al-Daccak R, Leveille C, Valet JP, Hebert J, Ouellette M, Mourad W. A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity Infection and Immunity. 63: 2826-2832. PMID 7622202 DOI: 10.1128/Iai.63.8.2826-2832.1995 |
0.385 |
|
| 1994 |
Al-Daccak R, Mehindate K, Hebert J, Rink L, Mecheri S, Mourad W. Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line Infection and Immunity. 62: 2409-2416. PMID 8188366 DOI: 10.1128/Iai.62.6.2409-2416.1994 |
0.482 |
|
| 1993 |
Mourad W, Al-Daccak R, Chatila T, Geha RS. Staphylococcal superantigens as inducers of signal transduction in MHC class II-positive cells Seminars in Immunology. 5: 47-55. PMID 8467095 DOI: 10.1006/Smim.1993.1007 |
0.516 |
|
| 1992 |
Khalil I, Deschamps I, Lepage V, al-Daccak R, Degos L, Hors J. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes. 41: 378-84. PMID 1551498 DOI: 10.2337/Diab.41.3.378 |
0.342 |
|
| 1992 |
Wang FQ, Al-Daccak R, Ju LY, Lethielleux P, Charron D, Loiseau P, Colombani J. HLA-DP distribution in Shanghai Chinese--a study by polymerase chain reaction--restriction fragment length polymorphism. Human Immunology. 33: 129-132. PMID 1348742 DOI: 10.1016/0198-8859(92)90063-S |
0.333 |
|
| 1992 |
Khalil I, Deschamps I, Lepage V, al-Daccak R, Degos L, Hors J. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes. 41: 378-384. DOI: 10.2337/Diabetes.41.3.378 |
0.325 |
|
| 1991 |
Khalil I, Lepage V, Douay C, Morin L, Al-Daccak R, Wallach D, Binet O, Lemarchand F, Degos L, Hors J. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. Journal of Investigative Dermatology. 97: 697-700. PMID 1940441 DOI: 10.1111/1523-1747.Ep12484029 |
0.423 |
|
| 1991 |
Al-Daccak R, Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P. Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. Human Immunology. 31: 277-285. PMID 1680839 DOI: 10.1016/0198-8859(91)90100-N |
0.387 |
|
| 1990 |
Al-Daccak R, Loiseau P, Miramont P, Rabian C, Raffoux C, Colombani J. Evaluation of HLA-class II identity between unrelated individuals by serological typing, DNA-RFLP method, and mixed lymphocyte reaction. Human Immunology. 29: 189-201. PMID 1980919 DOI: 10.1016/0198-8859(90)90114-5 |
0.442 |
|
| 1990 |
Al-Daccak R, Loiseau P, Rabian C, Devergie A, Bourdeau H, Raffoux C, Gluckman E, Colombani J. HLA-DR, DQ, and/or DP genotypic mismatches between recipient-donor pairs in unrelated bone marrow transplantation and transplant clinical outcome. Transplantation. 50: 960-964. PMID 1979452 DOI: 10.1097/00007890-199012000-00012 |
0.412 |
|
| Show low-probability matches. |